A digest of noteworthy publications curated by editors from McMaster University. This week’s focus: the effects of a restrictive vs liberal blood transfusion strategy in patients with acute myocardial infarction and anemia.
An updated overview of the mechanisms of action, therapeutic indications, efficacy, and safety of the currently available biologic disease-modifying antirheumatic drugs (bDMARDs) and targeted synthetic DMARDs (tsDMARDs), based on the results of randomized clinical trials and real-world studies.
Dr Gordon Guyatt, distinguished professor in the Department of Health Research Methods, Evidence, and Impact at McMaster University, discusses the latest findings on tocilizumab in the treatment of COVID-19.
The chapters discussing coronavirus disease 2019 (COVID-19) and vaccination against SARS-CoV-2 from the McMaster Textbook of Internal Medicine have just been updated to address new findings and emerging evidence.